ABSTRACT

Nasopharyngeal tumours are biologically distinct from the more common head and neck tumours and are characterized by their propensity for early lymphatic and distant metastatic spread. Anatomical constraints, together with widespread lymphatic permeation effectively exclude curative surgery. Radical radiotherapy is the mainstay of treatment though increasingly this is being combined with chemotherapy.